FI904157A0 - Cykliskt substituerade (kinolin-2-yl-metoxi) fenylaettikssyraderivat. - Google Patents

Cykliskt substituerade (kinolin-2-yl-metoxi) fenylaettikssyraderivat.

Info

Publication number
FI904157A0
FI904157A0 FI904157A FI904157A FI904157A0 FI 904157 A0 FI904157 A0 FI 904157A0 FI 904157 A FI904157 A FI 904157A FI 904157 A FI904157 A FI 904157A FI 904157 A0 FI904157 A0 FI 904157A0
Authority
FI
Finland
Prior art keywords
phenylettexyraderivat
cycliskt
kinolin
substituerade
metoxi
Prior art date
Application number
FI904157A
Other languages
English (en)
Finnish (fi)
Inventor
Klaus Mohrs
Siegfried Raddatz
Romanis Fruchtmann
Christian Kohlsdorfer
Reiner Mueller-Peddinghaus
Pia Theisen-Popp
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI904157A0 publication Critical patent/FI904157A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Lubricants (AREA)
  • Fats And Perfumes (AREA)
FI904157A 1989-08-24 1990-08-22 Cykliskt substituerade (kinolin-2-yl-metoxi) fenylaettikssyraderivat. FI904157A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3927930A DE3927930A1 (de) 1989-08-24 1989-08-24 Cyclisch substituierte (chinolin-2-yl-methoxy)phenyl-essig-saeure-derivate

Publications (1)

Publication Number Publication Date
FI904157A0 true FI904157A0 (fi) 1990-08-22

Family

ID=6387761

Family Applications (1)

Application Number Title Priority Date Filing Date
FI904157A FI904157A0 (fi) 1989-08-24 1990-08-22 Cykliskt substituerade (kinolin-2-yl-metoxi) fenylaettikssyraderivat.

Country Status (19)

Country Link
US (1) US5192771A (fr)
EP (1) EP0414076B1 (fr)
JP (1) JPH0390064A (fr)
KR (1) KR910004569A (fr)
CN (1) CN1049658A (fr)
AT (1) ATE112765T1 (fr)
AU (1) AU635305B2 (fr)
CA (1) CA2023829A1 (fr)
DD (1) DD298920A5 (fr)
DE (2) DE3927930A1 (fr)
DK (1) DK0414076T3 (fr)
ES (1) ES2060878T3 (fr)
FI (1) FI904157A0 (fr)
HU (1) HU209293B (fr)
IE (1) IE903073A1 (fr)
IL (1) IL95444A (fr)
NZ (1) NZ234996A (fr)
PT (1) PT95070A (fr)
ZA (1) ZA906707B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate
US5254581A (en) * 1990-06-21 1993-10-19 Imperial Chemical Industries Plc Pyran derivatives and their use as inhibitors of 5-lipoxygenase
US5304563A (en) * 1991-02-22 1994-04-19 Bayer Aktiengesellschaft 2-substituted quinolines, and their use in medicaments
DE4105551A1 (de) * 1991-02-22 1992-08-27 Bayer Ag 2-substituierte chinoline, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
EP0505122A1 (fr) * 1991-03-21 1992-09-23 Zeneca Limited Dérivés alpha, alpha-dialkylbenzyle
EP0540165A1 (fr) * 1991-10-03 1993-05-05 Zeneca Limited Dérivés d'acide alcanoique
DE4139749A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Chinolylmethoxyphenyl-essigsaeureamide
DE4226519A1 (de) * 1992-08-11 1994-02-17 Bayer Ag 3-Substituierte Chinolylmethoxy-phenylessigsäurederivate
US5300668A (en) * 1993-03-10 1994-04-05 Pfizer Inc. Certain esters of 1-(4-X-methylphenyl)cyclopent-3-ene-1-carboxylic acid, wherein X is a trialkylsilyloxy, bromo or hydroxy group, as intermediates
DE4443891A1 (de) * 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
CA2547518A1 (fr) 2003-12-12 2005-06-30 Wyeth Quinolines convenant pour le traitement de maladies cardio-vasculaires
KR101608702B1 (ko) * 2007-06-05 2016-04-04 사노피 디(헤테로)아릴사이클로헥산 유도체, 이들의 제조방법, 이들의 용도 및 이들을 포함하는 약제학적 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ213986A (en) * 1984-10-30 1989-07-27 Usv Pharma Corp Heterocyclic or aromatic compounds, and pharmaceutical compositions containing such
US4839369A (en) * 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4769461A (en) * 1986-09-16 1988-09-06 American Home Products Corporation Quinolinyl benzene hydroxamic acids as anti-inflammatory/antiallergic agents
EP0318093A3 (fr) * 1987-11-25 1990-12-05 Merck Frosst Canada Inc. Acides dicarboxyliques des diaryl quinoléines et leur utilisation comme médicaments
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
CA2013372A1 (fr) 1989-04-05 1990-10-05 Berthold Koch Purgeur pour circuits de pression
NZ233752A (en) * 1989-05-24 1993-05-26 Merck Frosst Canada Inc Substituted quinoline derivatives, preparation and pharmaceutical compositions thereof
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate

Also Published As

Publication number Publication date
IL95444A0 (en) 1991-06-30
CN1049658A (zh) 1991-03-06
ES2060878T3 (es) 1994-12-01
AU635305B2 (en) 1993-03-18
HU209293B (en) 1994-04-28
CA2023829A1 (fr) 1991-02-25
AU6108490A (en) 1991-02-28
DK0414076T3 (da) 1995-02-27
KR910004569A (ko) 1991-03-28
DD298920A5 (de) 1992-03-19
IL95444A (en) 1994-06-24
IE903073A1 (en) 1991-02-27
US5192771A (en) 1993-03-09
HUT54990A (en) 1991-04-29
JPH0390064A (ja) 1991-04-16
ZA906707B (en) 1991-06-26
PT95070A (pt) 1991-04-18
EP0414076A1 (fr) 1991-02-27
DE59007437D1 (de) 1994-11-17
NZ234996A (en) 1992-01-29
EP0414076B1 (fr) 1994-10-12
HU905305D0 (en) 1991-02-28
ATE112765T1 (de) 1994-10-15
DE3927930A1 (de) 1991-02-28

Similar Documents

Publication Publication Date Title
ES2054919T3 (es) Acidos y esteres 4-(quinolin-2-il-metoxi)fenilaceticos alfa-substituidos en caso dado.
DK162815C (da) Sugeflaske til medicinske formaal
DK250786D0 (da) Fortyknet, vandig rensemiddelkomposition
IS3152A7 (is) Aðferð við framleiðslu á nýjum lyfjablöndum með tempraðri losun á virka efninu
DE3674481D1 (de) Geraet zur herstellung von abdruckmassen.
FI944424A (fi) Elektrolyysikenno sterilointiliuosten valmistamiseksi joilla on suurempi otsonipitoisuus
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
FI904157A0 (fi) Cykliskt substituerade (kinolin-2-yl-metoxi) fenylaettikssyraderivat.
DE3670398D1 (de) Quelle fluessiger metallionen.
DE3684819D1 (de) Choline-ester-salze enthaltende pharmazeutische zusammensetzung zur erhoehung der absorption der magen-darmwege.
ATE106395T1 (de) Disubstituierte (chinolin-2-yl-methoxy) phenylessigsäure-derivate.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
NO862587D0 (no) Fremgangsmaate for fremstilling av en injiserbar opploesning inneholdende et antitumorantracyklin-glykosid.
DK538885D0 (da) Imidazolylalkylguanidinderivater, fremgangsmaade til fremstilling herafsamt laegemidler indeholdende disse forbindelser
DE3674040D1 (de) Pharmazeutische zusammensetzungen.
DE3681364D1 (de) Anellierte triazol-verbindungen.
DK89289D0 (da) Anvendelse af 1,4-dihydropyridin-derivater til fremstilling af laegemiddel til afvaenning af alkoholister
NO885315L (no) Homogen vandig opploesning for elektrolyttpaavisning.
DE58908775D1 (de) 2-Halogensubstituierte N-Indolylethyl-sulfonsäureamide, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln.
IT8520591A0 (it) Formulazione farmaceutica.
TR22222A (tr) Herbisid olarak kullanilabilen 1-aril-delta2-1,2-4-triazolin 5-onlar
DE3667915D1 (de) Pharmazeutische zusammensetzung.
IT8622041V0 (it) Dispositivo, per determinare il parallelismo per scopi odontoiatrici.
RO92329A2 (fr) Colonne d'absorbtion pour la preparation de solutions bisulfitiques
SE8701668D0 (sv) Forfarande for losningsmedelsabsorption

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: BAYER AKTIENGESELLSCHAFT